Kevin Harris, MD, PhD

Rank: Associate Professor

Division: Hematology & Oncology

Campus Address: SHEL 513

Mailing Address: 1720 2nd Avenue South, NP2540
                            Birmingham, AL 35294-3300

Phone: (205) 934-6995

Email: This email address is being protected from spambots. You need JavaScript enabled to view it.


For an appointment, call (205) 934-9999 or toll free 1 (800) UAB-8816.

Departmental Affiliation(s):
Primary: Medicine

Medical School:
University of Oklahoma Health Sciences Center, Oklahoma City

Internal Medicine Residency:
University of Minnesota, Minneapolis

Fellowship:
Hematology/Oncology, University of Minnesota, Minneapolis

Other Education:
PhD in Biochemistry: University of Oklahoma Health Sciences Center, Oklahoma City


Clinical Interests
Dr. Harris is a hematologist with clinical interests in benign hematology, particularly hemostasis and thrombosis. His research interests involve the role of inflammatory cytokines in cancer, and the biology of tumor microparticles. He is also active in human research ethics.


Selected Publications

1. Burns S, Arcasoy A, Li L, Kurian E, Selander K, Emanuel P, and Harris KW. Purification and characterization of the yeast-expressed erythropoietin mutant Epo (R103A), a specific inhibitor of human primary hematopoietic cell erythropoiesis. Blood 99 (12):4400-4405, 2002.

2. Selander KS*, Li L* 1, Watson L *, Merrell M, Dahmen H, C. Heinrich PC, Müller-Newen G, and Harris KW. Inhibition of cytokine receptor gp130 signaling in breast cancer cells blocks constitutive activation of Stat3 and inhibits in vivo malignancy. Cancer Research 64:6924-6933, 2004. (*authors contributed equally).

3. Ilvesaro JM, Merrell MA, Graves D, Rahko E, Jukkola-Vuorinen A, Vuopala KS,
Harris KW, and Selander KS. TLR9 mediates CpG-oligonucleotide-induced cellular invasion. Mol Cancer Res 2008;6(10), 2008

Publications: See a listing of publications on PubMed, a service of the National Library of Medicine.